Your browser doesn't support javascript.
loading
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Stahl, Maximilian; Derkach, Andriy; Farnoud, Noushin; Bewersdorf, Jan Philipp; Robinson, Troy; Famulare, Christopher; Cho, Christina; Devlin, Sean; Menghrajani, Kamal; Patel, Minal A; Cai, Sheng F; Miles, Linde A; Bowman, Robert L; Geyer, Mark B; Dunbar, Andrew; Epstein-Peterson, Zachary D; McGovern, Erin; Schulman, Jessica; Glass, Jacob L; Taylor, Justin; Viny, Aaron D; Stein, Eytan M; Getta, Bartlomiej; Arcila, Maria E; Gao, Qi; Barker, Juliet; Shaffer, Brian C; Papadopoulos, Esperanza B; Gyurkocza, Boglarka; Perales, Miguel-Angel; Abdel-Wahab, Omar; Levine, Ross L; Giralt, Sergio A; Zhang, Yanming; Xiao, Wenbin; Pai, Nidhi; Papaemmanuil, Elli; Tallman, Martin S; Roshal, Mikhail; Goldberg, Aaron D.
Afiliação
  • Stahl M; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Derkach A; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Farnoud N; Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Bewersdorf JP; Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Robinson T; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Famulare C; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cho C; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Devlin S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Menghrajani K; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, New York, USA.
  • Patel MA; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cai SF; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Miles LA; Weill Cornell Medical College, New York, New York, USA.
  • Bowman RL; Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Geyer MB; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Dunbar A; Weill Cornell Medical College, New York, New York, USA.
  • Epstein-Peterson ZD; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • McGovern E; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Schulman J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Glass JL; Weill Cornell Medical College, New York, New York, USA.
  • Taylor J; Center for Epigenetic Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Viny AD; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Stein EM; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Getta B; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Arcila ME; Weill Cornell Medical College, New York, New York, USA.
  • Gao Q; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Barker J; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Shaffer BC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Papadopoulos EB; Weill Cornell Medical College, New York, New York, USA.
  • Gyurkocza B; Weill Cornell Medical College, New York, New York, USA.
  • Perales MA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Abdel-Wahab O; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Levine RL; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Giralt SA; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Zhang Y; Weill Cornell Medical College, New York, New York, USA.
  • Xiao W; Sylvester Comprehensive Cancer Center at the University of Miami, Miami, Florida, USA.
  • Pai N; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Papaemmanuil E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Tallman MS; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Roshal M; Weill Cornell Medical College, New York, New York, USA.
  • Goldberg AD; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Am J Hematol ; 98(1): 79-89, 2023 01.
Article em En | MEDLINE | ID: mdl-36251406
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article